2024 Q2 Form 10-Q Financial Statement

#000139390524000172 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $728.7K $624.9K
YoY Change -48.3% -54.99%
Cost Of Revenue $544.0K $440.2K
YoY Change -10.73% -42.73%
Gross Profit $184.7K $184.6K
YoY Change -76.91% -70.21%
Gross Profit Margin 25.35% 29.54%
Selling, General & Admin $485.6K $115.2K
YoY Change 21.26% -80.35%
% of Gross Profit 262.86% 62.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.190K $4.370K
YoY Change -54.31% -55.32%
% of Gross Profit 2.27% 2.37%
Operating Expenses $485.6K $530.1K
YoY Change -51.56% -58.81%
Operating Profit -$300.8K -$345.4K
YoY Change 48.65% -48.22%
Interest Expense $98.63K -$20.53K
YoY Change -116.49% -113.04%
% of Operating Profit
Other Income/Expense, Net $98.63K $376.00
YoY Change -130.24% -100.12%
Pretax Income -$202.2K -$345.1K
YoY Change -61.74% -64.86%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$155.4K -$258.4K
YoY Change -71.74% -61.26%
Net Earnings / Revenue -21.32% -41.36%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 2.898B shares 2.898B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.02K $50.99K
YoY Change -74.11% -55.26%
Cash & Equivalents $38.02K $50.99K
Short-Term Investments
Other Short-Term Assets $14.40K $3.610K
YoY Change 453.85% 38.85%
Inventory $1.292M $1.436M
Prepaid Expenses
Receivables $5.010K $4.091K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.349M $1.495M
YoY Change -57.35% -52.73%
LONG-TERM ASSETS
Property, Plant & Equipment $10.48K $14.67K
YoY Change -70.99% -67.61%
Goodwill $2.781M $2.781M
YoY Change -51.05% -51.05%
Intangibles
YoY Change
Long-Term Investments $8.080K $8.080K
YoY Change 22.42% 22.42%
Other Assets
YoY Change
Total Long-Term Assets $2.965M $2.882M
YoY Change -50.4% -52.39%
TOTAL ASSETS
Total Short-Term Assets $1.349M $1.495M
Total Long-Term Assets $2.965M $2.882M
Total Assets $4.314M $4.377M
YoY Change -52.8% -52.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.074M $936.9K
YoY Change -36.15% -50.16%
Accrued Expenses $1.311M $1.252M
YoY Change 19.12% 26.81%
Deferred Revenue
YoY Change
Short-Term Debt $352.5K $105.1K
YoY Change -66.46% -89.24%
Long-Term Debt Due $699.4K $699.3K
YoY Change -9.02% -14.58%
Total Short-Term Liabilities $6.327M $6.220M
YoY Change 20.17% 26.53%
LONG-TERM LIABILITIES
Long-Term Debt $112.6K $112.7K
YoY Change -56.7% -56.89%
Other Long-Term Liabilities $281.8K $203.5K
YoY Change 290.72% 160.92%
Total Long-Term Liabilities $394.4K $316.2K
YoY Change 18.7% -6.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.327M $6.220M
Total Long-Term Liabilities $394.4K $316.2K
Total Liabilities $6.722M $6.536M
YoY Change 20.08% 24.38%
SHAREHOLDERS EQUITY
Retained Earnings -$24.32M -$24.13M
YoY Change 16.68% 18.96%
Common Stock $28.98K $28.98K
YoY Change 3811.34% 23463.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.887M $2.079M
YoY Change
Total Liabilities & Shareholders Equity $4.314M $4.377M
YoY Change -52.8% -52.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$155.4K -$258.4K
YoY Change -71.74% -61.26%
Depreciation, Depletion And Amortization $4.190K $4.370K
YoY Change -54.31% -55.32%
Cash From Operating Activities $8.880K -$356.8K
YoY Change -128.58% -45.66%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -21.85K $256.2K
YoY Change -134.17% -17.65%
NET CHANGE
Cash From Operating Activities 8.880K -$356.8K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities -21.85K $256.2K
Net Change In Cash -12.97K -$100.6K
YoY Change -139.46% -71.29%
FREE CASH FLOW
Cash From Operating Activities $8.880K -$356.8K
Capital Expenditures $0.00 $0.00
Free Cash Flow $8.880K -$356.8K
YoY Change -128.58% -46.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
333-150029
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
BERGIO INTERNATIONAL, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1338257
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12 Daniel Road E.
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fairfield
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07004
CY2024Q1 dei City Area Code
CityAreaCode
973
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
227-3230
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2898329407 shares
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Cash
Cash
50991 usd
CY2023Q4 us-gaap Cash
Cash
151553 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4091 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19433 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1436286 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1516990 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3610 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1900 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1494978 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1689876 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14667 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19037 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2780897 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2780897 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77985 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87001 usd
CY2024Q1 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
8082 usd
CY2023Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
6603 usd
CY2024Q1 us-gaap Assets
Assets
4376609 usd
CY2023Q4 us-gaap Assets
Assets
4583414 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
936919 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
860908 usd
CY2024Q1 us-gaap Bank Overdrafts
BankOverdrafts
4979 usd
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2024Q1 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
600299 usd
CY2023Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
542822 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
699338 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
699834 usd
CY2024Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
100136 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
87084 usd
CY2024Q1 us-gaap Subordinated Debt
SubordinatedDebt
634000 usd
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
634000 usd
CY2024Q1 fil Advances From Ceo And Accrued Interest
AdvancesFromCeoAndAccruedInterest
632839 usd
CY2023Q4 fil Advances From Ceo And Accrued Interest
AdvancesFromCeoAndAccruedInterest
364753 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
336690 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
360944 usd
CY2024Q1 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
51910 usd
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
73571 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19122 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23605 usd
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2203945 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2393369 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6220177 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6040890 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
112662 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
112166 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
58863 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
63396 usd
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
144627 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
148196 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
316152 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
323758 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6536329 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6364648 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 fil Convertible Series B Preferred Stock Value
ConvertibleSeriesBPreferredStockValue
0 usd
CY2023Q4 fil Convertible Series B Preferred Stock Value
ConvertibleSeriesBPreferredStockValue
0 usd
CY2024Q1 fil Convertible Series C Preferred Stock Value
ConvertibleSeriesCPreferredStockValue
0 usd
CY2023Q4 fil Convertible Series C Preferred Stock Value
ConvertibleSeriesCPreferredStockValue
0 usd
CY2024Q1 fil Convertible Series D Preferred Stock Value
ConvertibleSeriesDPreferredStockValue
9 usd
CY2023Q4 fil Convertible Series D Preferred Stock Value
ConvertibleSeriesDPreferredStockValue
10 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2898329407 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2101629305 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
28983 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
21016 usd
CY2024Q1 fil Common Stock Issuable Nyi
CommonStockIssuableNYI
1000000 shares
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax Attributable To Noncontrolling Interest
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToNoncontrollingInterest
-13077 usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax Attributable To Noncontrolling Interest
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToNoncontrollingInterest
-495503 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-358144 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-981975 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-486472 usd
CY2023Q4 fil Common Stock Issuable Nyi
CommonStockIssuableNYI
64575052 shares
CY2024Q1 fil Common Stock Issuable Value
CommonStockIssuableValue
10 usd
CY2023Q4 fil Common Stock Issuable Value
CommonStockIssuableValue
646 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26178074 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26105389 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24128545 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23769761 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2078531 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2357300 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
-4238251 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-4138534 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2159720 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1781234 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4376609 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4583414 usd
CY2024Q1 us-gaap Revenues
Revenues
624855 usd
CY2023Q1 us-gaap Revenues
Revenues
930586 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
440244 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
588998 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
184611 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
341588 usd
CY2024Q1 fil Selling And Marketing Expenses
SellingAndMarketingExpenses
18159 usd
CY2023Q1 fil Selling And Marketing Expenses
SellingAndMarketingExpenses
31024 usd
CY2024Q1 fil Professional And Consulting Expenses
ProfessionalAndConsultingExpenses
281156 usd
CY2023Q1 fil Professional And Consulting Expenses
ProfessionalAndConsultingExpenses
310081 usd
CY2024Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
133692 usd
CY2023Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
168006 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97047 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
138008 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
530054 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
647119 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-345443 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-305531 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19894 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25234 usd
CY2024Q1 fil Amortization Of Debt Discount And Deferred Financing Cost
AmortizationOfDebtDiscountAndDeferredFinancingCost
-26722 usd
CY2023Q1 fil Amortization Of Debt Discount And Deferred Financing Cost
AmortizationOfDebtDiscountAndDeferredFinancingCost
-19541 usd
CY2024Q1 fil Loss From Foreign Currency Transactions
LossFromForeignCurrencyTransactions
-403 usd
CY2023Q1 fil Loss From Foreign Currency Transactions
LossFromForeignCurrencyTransactions
-15 usd
CY2024Q1 fil Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-26491 usd
CY2023Q1 fil Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
136151 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1479 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
19424 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
376 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-180941 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-345067 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-486472 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-345067 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-93308 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-81682 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-6408 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-233238 usd
CY2024Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-99716 usd
CY2023Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-314920 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-251759 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-404790 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6669 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-262265 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-258428 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-667055 usd
CY2024Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
63706 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-322134 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-667055 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2602979442 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12319522 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4952287 usd
CY2023Q1 fil Series D Preferred Stock Issued For Cash Net Of Offering Cost
SeriesDPreferredStockIssuedForCashNetOfOfferingCost
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-317000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2023Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-10903 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-981975 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3642409 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1781234 usd
CY2024Q1 fil Common Stock Issued For Stock Issuables Value
CommonStockIssuedForStockIssuablesValue
0 usd
CY2024Q1 fil Issuance Of Common Stock For Debt Conversion Including Accrued Interest And Fees
IssuanceOfCommonStockForDebtConversionIncludingAccruedInterestAndFees
16002 usd
CY2024Q1 fil Issuance Of Common Stock For Conversion Of Preferred Stock Value
IssuanceOfCommonStockForConversionOfPreferredStockValue
307 usd
CY2024Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-36651 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-358144 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2159720 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-251759 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-404790 usd
CY2024Q1 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
-93308 usd
CY2023Q1 us-gaap Noncash Merger Related Costs
NoncashMergerRelatedCosts
-81682 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4370 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9781 usd
CY2024Q1 fil Amortization Of Debt Discount And Deferred Financing Costs
AmortizationOfDebtDiscountAndDeferredFinancingCosts
26722 usd
CY2023Q1 fil Amortization Of Debt Discount And Deferred Financing Costs
AmortizationOfDebtDiscountAndDeferredFinancingCosts
19541 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26491 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
136151 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
19424 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9016 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4225 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15342 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40078 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-80704 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30723 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1710 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1900 usd
CY2024Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1479 usd
CY2023Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
53890 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-153421 usd
CY2024Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
4979 usd
CY2023Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
-11582 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
57477 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
29624 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-9016 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4225 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-150687 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-467633 usd
CY2024Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-206070 usd
CY2023Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-98122 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-356757 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-565755 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4900 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4900 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
256195 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
112375 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
256195 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
112375 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
198745 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
256195 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311120 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-100562 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-259535 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
151553 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
373507 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50991 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
113972 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 fil Issuance Of Common Stock Issued For Convertible Debt Loans Payable And Accrued Interest
IssuanceOfCommonStockIssuedForConvertibleDebtLoansPayableAndAccruedInterest
13670 usd
CY2023Q1 fil Issuance Of Common Stock Issued For Convertible Debt Loans Payable And Accrued Interest
IssuanceOfCommonStockIssuedForConvertibleDebtLoansPayableAndAccruedInterest
0 usd
CY2024Q1 fil Issuance Of Common Stock Issued For Accrued Dividends Noncash
IssuanceOfCommonStockIssuedForAccruedDividendsNoncash
307 usd
CY2023Q1 fil Issuance Of Common Stock Issued For Accrued Dividends Noncash
IssuanceOfCommonStockIssuedForAccruedDividendsNoncash
0 usd
CY2024Q1 fil Deemed Dividend Upon Conversion Of Series D Preferred Stock And Accrued Dividends Noncash
DeemedDividendUponConversionOfSeriesDPreferredStockAndAccruedDividendsNoncash
63706 usd
CY2023Q1 fil Deemed Dividend Upon Conversion Of Series D Preferred Stock And Accrued Dividends Noncash
DeemedDividendUponConversionOfSeriesDPreferredStockAndAccruedDividendsNoncash
0 usd
CY2024Q1 fil Initial Amount Of Rou Asset And Related Liability Non Cash
InitialAmountOfRouAssetAndRelatedLiabilityNonCash
0 usd
CY2023Q1 fil Initial Amount Of Rou Asset And Related Liability Non Cash
InitialAmountOfRouAssetAndRelatedLiabilityNonCash
89830 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Note 1 - Nature of Operations and Basis of Presentation</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Organization and Nature of Operations</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Bergio International, Inc. (the “Company”) was incorporated in the State of Delaware on July 24, 2007 under the name Alba Mineral Exploration, Inc. On October 21, 2009, as a result of a Share Exchange Agreement, the corporation’s name was changed to Bergio International, Inc. On February 19, 2020, the Company changed its state of incorporation to Wyoming. The Company is engaged in the product design, manufacturing, distribution of fine jewelry primarily in the United States and is headquartered in Fairfield, New Jersey. The Company’s intent is to take advantage of the Bergio brand and establish a chain of retail stores worldwide. The Company’s branded product lines are products and/or collections designed by the Company’s designer and CEO, Berge Abajian, and will be the centerpiece of the Company’s retail stores.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On February 10, 2021, the Company entered into an Acquisition Agreement (“Acquisition Agreement”) with Digital Age Business, Inc., a Florida corporation, (“Digital Age Business”), pursuant to which the shareholders of Digital Age Business agreed to sell all of the assets and liabilities of its Aphrodite’s business to a subsidiary of the Company known as Aphrodite’s Marketing, Inc. (“Aphrodite’s Marketing”), a Wyoming corporation in exchange for Series B Preferred Stock of the Company. The Company owns 51% of Aphrodite’s Marketing.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On July 1, 2021 (“Closing”), the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with GearBubble, Inc., a Nevada corporation, (“GearBubble”), pursuant to which the shareholders of GearBubble (the “Equity Recipients”) agreed to sell 100% of the issued and outstanding shares of GearBubble to a subsidiary of the Company known as GearBubble Tech, Inc. (“GearBubble Tech”), a Wyoming corporation in exchange for $3,162,000 (the “Cash Purchase Price”), which shall be paid as follows: a) $2,000,000 (which was paid in cash at Closing), b) $1,162,000 to be paid in 15 equal installments, and c) 49,000 of the 100,000 authorized shares of the Merger Sub, such that upon the Closing, 51% of the Merger Sub shall be owned by the Company, and 49% of the Merger Sub shall be owned by the GearBubble Shareholders. The Company owns 51% of GearBubble Tech.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On March 24, 2021, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation. The amendment reflected the increase in the authorized shares of common stock from 1,000,000,000 shares to 3,000,000,000 shares. On July 9, 2021, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation. The amendment reflected the increase in the authorized shares of common stock from 3,000,000,000 shares to 6,000,000,000 shares. On April 28, 2022, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation and reflected the increase in the authorized shares of common stock from 6,000,000,000 shares to 9,000,000,000 shares.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On September 26, 2022, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation and reflected the increase in the authorized shares of common stock from 9,000,000,000 shares to 15,000,000,000 shares. In March 2023, the Company filed, with the Wyoming Secretary of State, a Certificate of Amendment, to amend its Articles of Incorporation and reflected the increase in the authorized shares of common stock from 15,000,000,000 shares to 25,000,000,000 shares. In the same Articles of Amendment, the Company filed for a reverse split of the Company’s common stock, at the ratio of 1 for 500 (the “Reverse Stock Split”), which was declared effective by Financial Industry Regulatory Authority (“FINRA”) effective April 17, 2023. All share and per-share data and amounts have been retroactively adjusted as of the earliest period presented in the unaudited condensed consolidated financial statements to reflect the Reverse Stock Split.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;margin-right:0.8pt;text-align:justify">As further described in Note 12, the Company presently expects to sell the Company’s majority owned subsidiary, Aphrodite’s Marketing<span style="font-size:9pt"> </span>due to declining revenues and is continually operating at loss. The Company is in negotiation with a potential buyer and has entered into a letter of intent in March 2024. Currently, no formal agreement or purchase agreement has been executed. Accordingly, Aphrodite’s Marketing’s business is characterized as Discontinued </p> <p style="font:10pt Times New Roman;margin:0;margin-right:0.8pt;text-align:justify">Operations in these condensed consolidated financial statements.  The assets and liabilities of Aphrodite’s Marketing have been presented separately in the Condensed Consolidated Balance Sheet as discontinued operations.  Similarly, the operating results and cash flows of discontinued operations are separately stated in those respective condensed consolidated financial statements.<span style="background-color:#FFFFFF"> </span>All prior year amounts from discontinued operations have been reclassified for consistency with the current year presentation.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Basis of Presentation</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information, which includes consolidated interim financial statements and present the consolidated interim financial statements of the Company and its wholly-owned and majority-owned subsidiaries as of March 31, 2024. All intercompany transactions and balances have been eliminated. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows have been made. Those adjustments consist of normal and recurring adjustments. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2023, and footnotes thereto included in the Company’s Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 29, 2024 (the “Annual Report”). The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the full year.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Non-controlling Interest in Consolidated Financial Statements</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">In December 2007, the Financial Accounting Standard Board (“FASB”) issued ASC 810-10-65, “Non-controlling Interests in consolidated financial statements, an amendment of Accounting Research Bulletin No. 51” (“SFAS No. 160”). This ASC clarifies that a non-controlling (minority) interest in a subsidiary is an ownership interest in the entity that should be reported as equity in the unaudited condensed consolidated financial statements. It also requires consolidated net income to include the amounts attributable to both the parent and non-controlling interest, with disclosure on the face of the consolidated income statement of the amounts attributed to the parent and to the non-controlling interest. In accordance with ASC 810-10- 45-21, those losses attributable to the parent and the non-controlling interest in subsidiaries may exceed their interests in the subsidiary’s equity. The excess and any further losses attributable to the parent and the non-controlling interest shall be attributed to those interests even if that attribution results in a deficit non-controlling interest balance.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On February 9, 2021, the Company entered into an Acquisition Agreement which resulted to the acquisition of 51% interest in Aphrodite’s Marketing. Additionally, on July 1, 2021, the Company entered into a Merger Agreement with GearBubble which resulted to the acquisition of 51% interest in the Merger Sub, GearBubble Tech. As of March 31, 2024 and December 31, 2023, the Company recorded a non-controlling interest balance of $(4,238,251) and $(4,138,534), respectively, in connection with the majority-owned subsidiaries, Aphrodite’s Marketing and GearBubble Tech as reflected in the accompanying unaudited condensed consolidated balance sheet and losses attributable to non-controlling interest of $99,716 and $314,920 during the three months ended March 31, 2024 and 2023, respectively as reflected in the accompanying unaudited condensed consolidated statements of operations.</p>
CY2021Q1 fil Business Acquisition Interest Acquired
BusinessAcquisitionInterestAcquired
0.51 pure
CY2021Q3 fil Total Selling Percentage
TotalSellingPercentage
1 pure
CY2021Q3 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
3162000 usd
CY2021Q3 fil Installment Description
InstallmentDescription
a) $2,000,000 (which was paid in cash at Closing), b) $1,162,000 to be paid in 15 equal installments, and c) 49,000 of the 100,000 authorized shares of the Merger Sub, such that upon the Closing, 51% of the Merger Sub shall be owned by the Company, and 49% of the Merger Sub shall be owned by the GearBubble Shareholders
CY2021Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
3000000000 shares
CY2021Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
6000000000 shares
CY2022Q2 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
9000000000 shares
CY2022Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
15000000000 shares
CY2023Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
25000000000 shares
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 500 (the “Reverse Stock Split”), which was declared effective by Financial Industry Regulatory Authority (“FINRA”) effective April 17, 2023
CY2021Q1 fil Business Acquisition Interest Acquired
BusinessAcquisitionInterestAcquired
0.51 pure
CY2021Q3 fil Business Acquisition Interest Acquired
BusinessAcquisitionInterestAcquired
0.51 pure
CY2024Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-99716 usd
CY2023Q1 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-314920 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-258428 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-356757 usd
CY2024Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
24100000 usd
CY2024Q1 fil Working Capital Deficit
WorkingCapitalDeficit
4700000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Use of Estimates</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from estimates. Significant estimates during the three months ended March 31, 2024 and 2023 include the estimates of useful lives of property and equipment, valuation of the operating lease liability and related right-of-use asset, valuation of derivatives, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the fair value of warrants issued with debt, the valuation allowance on deferred tax assets, and stock-based compensation.</p>
CY2024Q1 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Cost of revenues</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">Cost of revenue consists primarily of the cost of the merchandise, shipping fees, credit card processing services, fulfillment cost, ecommerce sellers’ pay-out; costs associated with operation and maintenance of the Company’s platform.</p>
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
18159 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
31024 usd
CY2024Q1 fil Total Derivative Liabilities
TotalDerivativeLiabilities
388600 usd
CY2023Q4 fil Total Derivative Liabilities
TotalDerivativeLiabilities
434515 usd
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b>Concentration Risk</b></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><span style="border-bottom:1px solid #000000"><i>Concentration of Revenues</i></span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">For the three months ended March 31, 2024 and 2023, no customer accounted for over 10% of total revenues.</p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><span style="border-bottom:1px solid #000000"><i>Concentration of Purchases</i></span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company purchased approximately 61% of its finished products from three vendors (12%, 20% and 29%) during the three months ended March 31, 2024. The Company purchased approximately 18% of its finished products from one vendor during the three months ended March 31, 2023.</p> <p style="font:10pt Times New Roman;margin:0"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><span style="border-bottom:1px solid #000000"><i>Concentration of Accounts Receivable</i></span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">As of March 31, 2024, accounts receivable amounted to $4,091 and one customer represented 55% of this balance. As of December 31, 2023, total accounts receivable amounted to $19,433 and one customer represented 82% of this balance.</p>
CY2024Q1 fil Concentration Risk Percentage Purchases
ConcentrationRiskPercentagePurchases
0.61 pure
CY2023Q4 fil Concentration Risk Percentage Purchases
ConcentrationRiskPercentagePurchases
0.18 pure
CY2024Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4091 usd
CY2024Q1 fil Concentration Risk Percentage Accounts Receivable
ConcentrationRiskPercentageAccountsReceivable
0.55 pure
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
19433 usd
CY2023Q4 fil Concentration Risk Percentage Accounts Receivable
ConcentrationRiskPercentageAccountsReceivable
0.82 pure
CY2024Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
391722 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
391722 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
581352 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
581352 usd
CY2024Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
8354 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
8354 usd
CY2024Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
25411 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
25411 usd
CY2024Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1006839 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
1006839 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
992172 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
987802 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14667 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19037 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4370 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9781 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41094374805 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21806071136 shares
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
134946 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
148617 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
34810 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
61533 usd
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
100136 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
87084 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
388600 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
434515 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
434515 usd
CY2024Q1 fil Initial Valuation Of Derivative Liabilities Included In Derivative Expense
InitialValuationOfDerivativeLiabilitiesIncludedInDerivativeExpense
-19424 usd
CY2024Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
26491 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
388600 usd
CY2024Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
812000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
812000 usd
CY2024Q1 fil Less Notes Payable Current Portion
LessNotesPayableCurrentPortion
-699338 usd
CY2023Q4 fil Less Notes Payable Current Portion
LessNotesPayableCurrentPortion
-699834 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
112662 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
112166 usd
CY2024Q1 fil Minimum Principal Payments Notes Payable
MinimumPrincipalPaymentsNotesPayable
812000 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
18765 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
23370 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
23484 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
20842 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
4032 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
90493 usd
CY2024Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
12508 usd
CY2024Q1 fil Less Amounts Representing Interest Lease Payments
LessAmountsRepresentingInterestLeasePayments
77985 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
19122 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
58863 usd
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
100000000 shares
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
634000 usd
CY2023 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
317000 usd
CY2024Q1 us-gaap Subordinated Debt
SubordinatedDebt
634000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
142176 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
105832 usd
CY2024Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-36651 usd
CY2023Q1 fil Accrued Dividends On Preferred Stock
AccruedDividendsOnPreferredStock
-10903 usd
CY2021Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
3000000000 shares
CY2021Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
6000000000 shares
CY2022Q2 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
9000000000 shares
CY2022Q3 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
15000000000 shares
CY2023Q1 fil Increase In Authorized Common Shares
IncreaseInAuthorizedCommonShares
25000000000 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
32595983 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.07
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
32595983 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.07
CY2024Q1 fil Number Of Warrants Exercisable
NumberOfWarrantsExercisable
32595983 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.07
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
13144 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
457777 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
0 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
179663 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
13144 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
278114 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
6804 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
88119 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
24261 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
639664 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-11117 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-361550 usd
CY2024Q1 fil Aphrodite Sba Outstanding Balance
AphroditeSbaOutstandingBalance
150000 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
1960 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
132224 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
1960 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
133953 usd
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax Attributable To Noncontrolling Interest
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToNoncontrollingInterest
-13077 usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax Attributable To Noncontrolling Interest
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToNoncontrollingInterest
-495503 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Cash
DisposalGroupIncludingDiscontinuedOperationCash
0 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Cash
DisposalGroupIncludingDiscontinuedOperationCash
0 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
0 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
0 usd
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Intangible Assets
DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
0 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets
DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
0 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Goodwill Noncurrent
DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
0 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill Noncurrent
DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
0 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
782729 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
975721 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
5373 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
1805 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
1415843 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
1415843 usd
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2203945 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2393369 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
144627 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
148196 usd
CY2024Q1 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
1415843 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
1415843 usd
CY2023 us-gaap Interest Expense Deposits
InterestExpenseDeposits
95703 usd
CY2023 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
29000 usd
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
157274 usd
CY2021 fil Aphrodite Sba Loan Assumed
AphroditeSbaLoanAssumed
150000 usd
CY2022Q4 fil Aphrodite Sba Outstanding Balance
AphroditeSbaOutstandingBalance
150000 usd
CY2022Q4 fil Aphrodite Sba Accrued Expense
AphroditeSbaAccruedExpense
14627 usd
CY2023Q4 fil Aphrodite Sba Outstanding Balance
AphroditeSbaOutstandingBalance
150000 usd
CY2023Q4 fil Aphrodite Sba Accrued Expense
AphroditeSbaAccruedExpense
20550 usd
CY2024Q1 fil Aphrodite Sba Accrued Expense
AphroditeSbaAccruedExpense
22155 usd

Files In Submission

Name View Source Status
0001393905-24-000172-index-headers.html Edgar Link pending
0001393905-24-000172-index.html Edgar Link pending
0001393905-24-000172.txt Edgar Link pending
0001393905-24-000172-xbrl.zip Edgar Link pending
brgo-20240331.htm Edgar Link pending
brgo-20240331.xsd Edgar Link pending
brgo_ex311.htm Edgar Link pending
brgo_ex312.htm Edgar Link pending
brgo_ex321.htm Edgar Link pending
brgo_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
brgo-20240331_def.xml Edgar Link unprocessable
brgo-20240331_lab.xml Edgar Link unprocessable
brgo-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brgo-20240331_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brgo-20240331_cal.xml Edgar Link unprocessable